Darla Hilliard

Darla Hilliard serves as the Associate Director of Commercial Training, Development and Execution at ANI Pharmaceuticals, Inc. since January 2022, focusing on the launch of purified cortrophin gel within ultra rare and rare disease areas, particularly in Rheumatology, Nephrology, Ophthalmology, Neurology, and Dermatology. Prior experience includes roles as Regional Account Manager at Alexion Pharmaceuticals, where Darla launched Soliris targeting Myasthenia Gravis and Neuromyelitis Optica, and various positions at Mallinckrodt Pharmaceuticals, specializing in immunology, autoimmune, and rare diseases. Additional roles were held at Novartis, AstraZeneca, and Valeant Pharmaceuticals, with notable achievements in sales and relationship management across multiple therapeutic areas. Darla holds a Master of Science degree in Speech and Language Pathology from Eastern Washington University.